Market Cap (In INR)
256.5 Million
Revenue (In INR)
2.34 Million
Net Income (In INR)
-6.55 Million
Avg. Volume
32.51 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.75-7.9
- PE
- -97.5
- EPS
- -0.04
- Beta Value
- 1.03232
- ISIN
- INE773D01018
- CUSIP
- -
- CIK
- -
- Shares
- 65769999.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- K. Koteswara Rao
- Employee Count
- -
- Website
- http://www.transgenebiotek.com
- Ipo Date
- 2001-12-31
- Details
- Transgene Biotek Ltd. is a biotechnology company, which manufactures and sells diagnostic kits. It involves in the production and oral formulation of different proteins using TrabiORAL technology. The firm's products portfolio includes TrabiDHA, Tacrolimus, and Orlistat. The company was founded by K. Koteswara Rao in 1991 and is headquartered in Hyderabad, India.
More Stocks
-
SHYAMTELShyam Telecom Limited
SHYAMTEL
-
FMOCF
-
KIMS
-
BLIBQBB Liquidating Inc.
BLIBQ
-
ZTLLFZonetail Inc.
ZTLLF
-
TBR
-
JSE
-
NICLNichols plc
NICL